…e peptide-1 (GLP-1) receptor agonists are increasingly used for metabolic disease, but their safety profile in patients with chronic pancreatitis…
metabolic disease
This disease is selected. Its supporting articles are shown below.
Articles mentioning metabolic disease
8 articles · page 1 of 1…ased risk of chronic diseases including cardiovascular disease, metabolic disease, depression and dementia. The underlying mechanisms remain uncl…
…peptide-1 receptor agonists (GLP-1RAs) are increasingly used in cardiometabolic disease for their anti-obesity and anti-diabetic effects, showing great…
…kely to have LT (sHR 3.80, 95% CI 1.31 to 10.98). Patients with metabolic disease were nearly five times (sHR 5.05, 95% CI 3.60 to 7.08) and thos…
…on and trial duration: a retrospective cross-sectional study of metabolic disease trials. BMJ Open 2026;16:e103938. doi: 10.1136/bmjopen-2025-103…
…centralised clinical trial (DCT) adoption and trial duration in metabolic disease trials.Design Retrospective cross-sectional analysis using anal…
…ffect modification by inflammatory markers and risk factors for metabolic disease. BMC Med. 2023;21:488.…
…ients with COPD and type 2 inflammation, regardless of comorbid CVD or metD.…